======= GPR37L1 =======
== Gene Information ==
* **Official Symbol**: GPR37L1
* **Official Name**: G protein-coupled receptor 37 like 1
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9283|9283]]
* **UniProt**: [[https://www.uniprot.org/uniprot/O60883|O60883]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=GPR37L1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20GPR37L1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/617630|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Receptor for the neuroprotective and glioprotective factor prosaposin. Ligand binding induces endocytosis, followed by an ERK phosphorylation cascade. {ECO:0000269|PubMed:23690594}.
|7tm 1|
|prosaposin receptor activity|
|positive regulation of cerebellar granule cell precursor proliferation|
|regulation of cerebellar granule cell precursor proliferation|
|negative regulation of astrocyte differentiation|
|negative regulation of hydrogen peroxide-induced cell death|
|negative regulation of response to reactive oxygen species|
|negative regulation of systemic arterial blood pressure|
|negative regulation of cellular response to drug|
|regulation of hydrogen peroxide-induced cell death|
|negative regulation of glial cell differentiation|
|regulation of astrocyte differentiation|
|negative regulation of response to drug|
|negative regulation of smoothened signaling pathway|
|regulation of response to reactive oxygen species|
|regulation of cellular response to drug|
|G protein-coupled peptide receptor activity|
|negative regulation of gliogenesis|
|negative regulation of blood pressure|
|negative regulation of oxidative stress-induced cell death|
|negative regulation of cellular response to oxidative stress|
|negative regulation of response to oxidative stress|
|peptide binding|
|positive regulation of neural precursor cell proliferation|
|ciliary membrane|
|regulation of oxidative stress-induced cell death|
|regulation of glial cell differentiation|
|regulation of cellular response to oxidative stress|
|regulation of smoothened signaling pathway|
|adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway|
|regulation of response to oxidative stress|
|regulation of neural precursor cell proliferation|
|regulation of systemic arterial blood pressure|
|regulation of response to drug|
|regulation of gliogenesis|
|regulation of blood pressure|
|receptor complex|
|adenylate cyclase-modulating G protein-coupled receptor signaling pathway|
|negative regulation of neuron differentiation|
|G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger|
|negative regulation of neurogenesis|
|negative regulation of nervous system development|
|negative regulation of cell development|
|blood circulation|
|circulatory system process|
|positive regulation of nervous system development|
|positive regulation of MAPK cascade|
|regulation of neuron differentiation|
|negative regulation of cell differentiation|
|G protein-coupled receptor activity|
|regulation of cellular response to stress|
|regulation of MAPK cascade|
|regulation of neurogenesis|
|positive regulation of cell population proliferation|
|regulation of nervous system development|
|regulation of cell development|
|negative regulation of developmental process|
|negative regulation of cell death|
|positive regulation of protein phosphorylation|
|positive regulation of intracellular signal transduction|
|positive regulation of phosphorylation|
|positive regulation of phosphorus metabolic process|
|positive regulation of phosphate metabolic process|
|negative regulation of multicellular organismal process|
|positive regulation of protein modification process|
|negative regulation of signal transduction|
|G protein-coupled receptor signaling pathway|
|negative regulation of cell communication|
|negative regulation of signaling|
|positive regulation of developmental process|
|regulation of protein phosphorylation|
|regulation of response to stress|
|generation of neurons|
|regulation of phosphorylation|
|positive regulation of cellular protein metabolic process|
|regulation of cell population proliferation|
|negative regulation of response to stimulus|
|neurogenesis|
|positive regulation of signal transduction|
|regulation of cell death|
|positive regulation of protein metabolic process|
|positive regulation of multicellular organismal process|
|regulation of phosphate metabolic process|
|regulation of phosphorus metabolic process|
|regulation of cell differentiation|
|positive regulation of cell communication|
|positive regulation of signaling|
|regulation of intracellular signal transduction|
|regulation of protein modification process|
|system process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp132|Metformin 40μM R03 exp132]]|-1.74|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 12161
* **Expression level (log2 read counts)**: 2.09
{{:chemogenomics:nalm6 dist.png?nolink |}}